Amphenol Corp. Cl A (0HFB)
London Exchange · UK · prices in USD · close of 22 Oct 2026
Key indicators
| Last close | USD 72.64 |
|---|---|
| 52-week range | 9.89 – 91.86 |
| Return, 1 month / 3 months | −11.8% / −7.7% |
| Return, 1 year / 3 years | +14.4% / +273.5% |
| Trend | Below its 200-day average |
| RSI (14) | 32 |
| Volatility (1 year) | 308.5% |
| Worst drawdown (1 year) | -88.8% |
| Average daily value traded | 1.40M USD |
| Dividend yield | 1.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Amphenol makes electrical, electronic and fiber optic connectors, interconnect systems, antennas and sensors. Its products are used in vehicles, broadband networks, commercial aircraft, industrial equipment, data communications, mobile devices and military systems. Customers are equipment makers and network operators that need reliable ways to connect and sense within their products. The company is based in Wallingford, Connecticut, in the United States, and supplies manufacturers and service providers in many countries around the world.
The shares are listed on the London Exchange in UK under the code 0HFB, and the price on this page is in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Amphenol Corp. Cl A (0HFB) trades on the London Exchange in UK. It last closed at USD 72.64 on 22 October 2026.
Its price-based Market X-Ray is 41 out of 100 (a weak price profile), ranking 2,583 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 14.4% and over the last three months it fell 7.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 57 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -2.7% | ||
| From 52-week high | -18.6% | ||
| Momentum | 52 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -7.7% | ||
| 6-month return | -0.9% | ||
| 12-month return, skipping the last month | 29.6% | ||
| Stability (higher is calmer) | 1 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 308.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -88.8% | ||
| Liquidity | 56 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.40M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 52 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 1.2% | ||
| Years with dividends | 6 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −9.8% |
|---|---|
| 1 month | −11.8% |
| 3 months | −7.7% |
| 6 months | −0.9% |
| 1 year | +14.4% |
| 3 years | +273.5% |
| 5 years | +283.4% |
Signals
| 50-day / 200-day average | 81.81 / 74.65 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.14 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 21 Sep 2026 | USD 0.1250 |
| 22 Jun 2026 | USD 0.2500 |
| 20 Mar 2026 | USD 0.2500 |
| 15 Dec 2025 | USD 0.2500 |
| 15 Sep 2025 | USD 0.1650 |
| 16 Jun 2025 | USD 0.1650 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.